You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Medical Care

IVD Antibodies Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Summary

Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.

The global IVD Antibodies market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.

Based on the type of product, the global IVD Antibodies market segmented into
Cardiac Markers
Tumor Markers
Kidney Injury Markers

Based on the end-use, the global IVD Antibodies market classified into
Hospital
Specialty Clinic
Diagnostic Center
Others

Based on geography, the global IVD Antibodies market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]

And the major players included in the report are
Abcam
Thermo Fisher Scientific
Rockland Immunochemicals
GenScript
Bio-Rad Laboratories
SDIX
MEDICAL & BIOLOGICAL LABORATORIES
HyTest
Abbott
Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL IVD ANTIBODIES INDUSTRY
2.1 Summary about IVD Antibodies Industry
2.2 IVD Antibodies Market Trends
2.2.1 IVD Antibodies Production & Consumption Trends
2.2.2 IVD Antibodies Demand Structure Trends
2.3 IVD Antibodies Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Cardiac Markers
4.2.2 Tumor Markers
4.2.3 Kidney Injury Markers
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Hospital
4.3.2 Specialty Clinic
4.3.3 Diagnostic Center
4.3.4 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Cardiac Markers
5.2.2 Tumor Markers
5.2.3 Kidney Injury Markers
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Hospital
5.3.2 Specialty Clinic
5.3.3 Diagnostic Center
5.3.4 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Cardiac Markers
6.2.2 Tumor Markers
6.2.3 Kidney Injury Markers
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Hospital
6.3.2 Specialty Clinic
6.3.3 Diagnostic Center
6.3.4 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Cardiac Markers
7.2.2 Tumor Markers
7.2.3 Kidney Injury Markers
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Hospital
7.3.2 Specialty Clinic
7.3.3 Diagnostic Center
7.3.4 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Cardiac Markers
8.2.2 Tumor Markers
8.2.3 Kidney Injury Markers
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Hospital
8.3.2 Specialty Clinic
8.3.3 Diagnostic Center
8.3.4 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Cardiac Markers
9.2.2 Tumor Markers
9.2.3 Kidney Injury Markers
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Hospital
9.3.2 Specialty Clinic
9.3.3 Diagnostic Center
9.3.4 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Abcam
10.1.2 Thermo Fisher Scientific
10.1.3 Rockland Immunochemicals
10.1.4 GenScript
10.1.5 Bio-Rad Laboratories
10.1.6 SDIX
10.1.7 MEDICAL & BIOLOGICAL LABORATORIES
10.1.8 HyTest
10.1.9 Abbott
10.2 IVD Antibodies Sales Date of Major Players (2017-2020e)
10.2.1 Abcam
10.2.2 Thermo Fisher Scientific
10.2.3 Rockland Immunochemicals
10.2.4 GenScript
10.2.5 Bio-Rad Laboratories
10.2.6 SDIX
10.2.7 MEDICAL & BIOLOGICAL LABORATORIES
10.2.8 HyTest
10.2.9 Abbott
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
  • FORMAT: PDF
  • PUBLISHED DATE: Jan, 2021
  • NO OF PAGES: 96